Tyrosine kinase receptors as attractive targets of cancer therapy.
about
RETRACTED: A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cell death control.Tyrosine kinase - Role and significance in Cancer.Identification and characterization of high affinity antisense PNAs for the human unr (upstream of N-ras) mRNA which is uniquely overexpressed in MCF-7 breast cancer cells.Advances in targeted therapies and new promising targets in esophageal cancerCrucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2Immunohistochemical analysis of receptor tyrosine kinase signal transduction activity in chordomaFGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosisLapatinib: a novel dual tyrosine kinase inhibitor with activity in solid tumorsComprehensive analysis of receptor tyrosine kinase activation in human melanomas reveals autocrine signaling through IGF-1RImmunohistochemical expression of receptor tyrosine kinase PDGFR-α, c-Met, and EGFR in skull base chordoma.Compositional analysis of heparin/heparan sulfate interacting with fibroblast growth factor.fibroblast growth factor receptor complexesMolecular mechanisms of acquired resistance to tyrosine kinase targeted therapyAnti-proliferative role of recombinant lethal toxin of Bacillus anthracis on primary mammary ductal carcinoma cells revealing its therapeutic potential.Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunitiesInhibition of the receptor tyrosine kinase ROR1 by anti-ROR1 monoclonal antibodies and siRNA induced apoptosis of melanoma cellsThe tyrosine kinase receptor ROR1 is constitutively phosphorylated in chronic lymphocytic leukemia (CLL) cells.Targeting pancreatic islets with phage display assisted by laser pressure catapult microdissection.Receptor tyrosine kinases and their hormonal regulation in uterine leiomyomaUse of protein array technology to investigate receptor tyrosine kinases activated in hepatocellular carcinomaRole of ErbB Receptors in Cancer Cell Migration and InvasionDifferential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomasA review of lapatinib ditosylate in the treatment of refractory or advanced breast cancer.Muscarinic receptor agonists and antagonists: effects on cancerProtein kinases as targets for cancer treatment.Identification of caveolin-1 as a potential causative factor in the generation of trastuzumab resistance in breast cancer cells.The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic targetInduction of antagonistic soluble decoy receptor tyrosine kinases by intronic polyA activation.Imaging of EGFR and EGFR tyrosine kinase overexpression in tumors by nuclear medicine modalities.A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor.T-cell antigen receptor (TCR) transmembrane peptides: A new paradigm for the treatment of autoimmune diseases.Receptor tyrosine kinases and their activation in melanoma.Mechanism of cell adaptation: when and how do cancer cells develop chemoresistance?Modulation of gap junction channels and hemichannels by growth factors.Novel immune modulators used in hematology: impact on NK cellsShort peptides interfering with signaling pathways as new therapeutic tools for cancer treatment.Biological effect of tyrosine kinase inhibitors on three canine mast cell tumor cell lines with various KIT statuses.Peptide-based interference of the transmembrane domain of neuropilin-1 inhibits glioma growth in vivo.A growth-suppressive function for the c-fes protein-tyrosine kinase in colorectal cancer.Self-association of models of transmembrane domains of ErbB receptors in a lipid bilayerA Comparative Approach of Tumor-Associated Inflammation in Mammary Cancer between Humans and Dogs.
P2860
Q24540107-40A9C539-DE2C-405E-A31F-6DD3862AF1CFQ24791430-2DA8DA15-4AB5-4904-9670-57D62FA9535CQ24813771-C748AB35-2D60-4102-9F2C-C929E4EAC6EAQ26825957-A875A735-2D55-4F9B-BB39-C8AC8AEC9714Q28115187-A7514AA2-B848-49ED-8585-AD64AC3A22DAQ28255507-E42D76ED-1C06-4194-89D9-B5295C4D1180Q28289695-73C64650-81C7-41DD-9B30-750ECDB56A59Q28292264-4D211264-D1BA-4CE9-93DD-92E8F2A20A8AQ30425784-02980583-E73C-4C73-8201-7D0BACC587B4Q33275402-8F10C9EC-1204-4AB9-8663-F7B36BB23DE3Q33480621-D9DF63DC-93A3-49D6-A4AB-0433F0A58410Q33828409-35E8272D-A35D-426B-A8CE-BEEB6B12BD16Q33829335-9D0082E8-A3B9-40C9-A875-97A5D7D9EEE4Q34139691-C6CE10A3-F5E6-4B4E-A2FC-C8B1417C71D3Q34674715-E407ACBA-6876-4784-914F-2B66AE402E7BQ35036351-E3064532-84AA-41C4-81B0-309CC1F69EA0Q35083665-E4546047-1CE5-417A-B4E1-C7F9B8513A45Q35244896-2724FAC6-ACCC-46E0-A502-019E9FFEBD72Q36230812-95FAAC76-DB02-4C57-93F5-8B5688D6BB12Q36311027-3DD14D24-9B66-4EA0-A852-9E5D06E46D5AQ36409237-ABDA1083-6F4D-4656-A0D8-BF042018B81AQ36642955-E7BDCF25-D997-4D34-A4EF-C4A36A8CE7C8Q36706667-369B1339-8694-45A3-9CDD-6027C786D18AQ36918131-F9203E7F-215A-4436-AF25-3922EDFF6169Q36983366-3704CB46-5397-417D-AF37-8D19C621355FQ37182283-D751E748-609C-4C41-A605-ABF26EA5317CQ37194653-F3BA7198-F28D-4115-9923-E503929E3FF2Q37320501-6A35B9F6-5200-407E-AAD1-9F33DB0D1B54Q37691482-84BA13C8-A45C-40B7-8AF2-71AA413A65E0Q37739764-9060F06F-367A-4107-90E5-5C7346735AF6Q37841746-9125B583-CCFF-432D-B8B8-73E8562B014CQ37856115-B455C107-4A20-41FF-8302-C14FAF935007Q37973241-35886F4B-2C14-4F7C-BE71-E34E5651F47DQ38073760-522A5068-5552-4DE6-BE7A-38CE7E33052EQ38767147-CB693A6F-FC30-4DB9-B447-188CD98DADE2Q39560865-1A667A35-0278-492A-BACA-1992EB56770EQ39742289-B06523EB-FFA5-4684-851B-F801C75E4AFEQ40321346-346AF5C8-A45A-40CB-9840-7218873F90D7Q41151906-1412E43E-7885-439A-B70B-9A1A21F56C98Q42344612-1C91CCDE-E8A1-4D71-80C4-19F9217F7C74
P2860
Tyrosine kinase receptors as attractive targets of cancer therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Tyrosine kinase receptors as attractive targets of cancer therapy.
@ast
Tyrosine kinase receptors as attractive targets of cancer therapy.
@en
type
label
Tyrosine kinase receptors as attractive targets of cancer therapy.
@ast
Tyrosine kinase receptors as attractive targets of cancer therapy.
@en
prefLabel
Tyrosine kinase receptors as attractive targets of cancer therapy.
@ast
Tyrosine kinase receptors as attractive targets of cancer therapy.
@en
P2093
P1476
Tyrosine kinase receptors as attractive targets of cancer therapy.
@en
P2093
Amar Bennasroune
Anne Gardin
Dominique Aunis
Gérard Crémel
Pierre Hubert
P356
10.1016/J.CRITREVONC.2003.08.004
P577
2004-04-01T00:00:00Z